Devices › Drug eluting permanent left ventricular (lv) pacemaker electrode
Device brand name · Drug eluting permanent left ventricular lv pacemaker electrode
Drug Eluting Permanent Left Ventricular Lv Pacemaker Electrode: medical device reports filed with FDA
1,234 reports name it, 2023–2026. Manufacturer given most often on reports: Medtronic. Product code OJX.
- 1,234
- device reports naming the brand
- 0% of all MAUDE reports · about 412 a year
- 80
- reports, 12 months to August 2026
- 97 in the 12 months before
- 65.5%
- classified as malfunction
- 40.2% across the product code
- 0.3%
- classified as death, as reported
- 4 reports · not verified by FDA
1,234 medical device reports received by FDA name the brand "Drug Eluting Permanent Left Ventricular Lv Pacemaker Electrode" (drug eluting permanent left ventricular lv pacemaker electrode); the manufacturer given most often on reports is Medtronic; received from July 2023 to June 2026. Brand names are as the reporter or manufacturer wrote them, so one product can appear under several spellings.
80 reports arrived in the 12 months to August 2026, down 18% from 97 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are malfunction (65.5%), injury (34.1%) and death (0.3%); across all drug eluting permanent left ventricular (lv) pacemaker electrode reports (product code OJX) death is recorded in 3.5% and malfunction in 40.2%. Event type is the reporter's classification of the report, not a verified outcome.
The device problems coded most often are insufficient device problem information (14.5%), failure to capture (6.6%) and therapeutic or diagnostic output failure (6.2%). The patient problems coded most often are failure of implant, device overstimulation of tissue and undesired nerve stimulation. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Reports by month, five years
Reports by the month FDA received them. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.
By year received
Event type and report source
Event type, as classified on the report
Who filed the report
Grey bar: all 52,462 reports carrying product code OJX. Event type is the filer's classification and is not verified by FDA.
Device problems coded
| Device problem (FDA code) | Reports | Share | Share across product code |
|---|---|---|---|
| Insufficient device problem information | 179 | 14.5% | 2.2% |
| Failure to capture | 81 | 6.6% | 15.6% |
| Therapeutic or diagnostic output failure | 77 | 6.2% | 0.2% |
| Device dislodged or dislocated | 74 | 6% | 23.6% |
| High capture threshold | 52 | 4.2% | 15.9% |
| Impedance problem | 51 | 4.1% | 2.4% |
| High impedance | 50 | 4.1% | 8.6% |
| Pacing problem | 45 | 3.6% | 1% |
| Inappropriate/inadequate shock/stimulation | 41 | 3.3% | 0.2% |
| Over-sensing | 39 | 3.2% | 1% |
| Signal artifact/noise | 31 | 2.5% | 0.4% |
| High sensing threshold | 20 | 1.6% | 0.7% |
| Output problem | 19 | 1.5% | 0.1% |
| Positioning problem | 18 | 1.5% | 2.9% |
| No pacing | 15 | 1.2% | 0.1% |
| Product quality problem | 15 | 1.2% | 0% |
| Device sensing problem | 14 | 1.1% | 0.7% |
| Defective component | 11 | 0.9% | 0% |
| Patient device interaction problem | 11 | 0.9% | 0% |
| Patient-device incompatibilitythe device did not suit the patient | 11 | 0.9% | 0.7% |
FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.
Patient problems coded
| Patient problem (FDA code) | Reports | Share |
|---|---|---|
| Failure of implant | 51 | 4.1% |
| Device overstimulation of tissue | 30 | 2.4% |
| Undesired nerve stimulation | 24 | 1.9% |
| Sepsisa severe body-wide response to infection | 22 | 1.8% |
| Shock from patient lead(s) | 14 | 1.1% |
| Pocket erosion | 13 | 1.1% |
| Foreign body in patientpart of a device left in the patient | 12 | 1% |
| Syncope/fainting | 7 | 0.6% |
| Atrial fibrillationan irregular heart rhythm | 6 | 0.5% |
| Asystole | 5 | 0.4% |
| Obstruction/occlusion | 5 | 0.4% |
| Twiddlers syndrome | 5 | 0.4% |
| Discomfortdiscomfort | 4 | 0.3% |
| Erosion | 4 | 0.3% |
| Falla fall | 4 | 0.3% |
Patient problem codes are present mainly in reports filed since 2019 and are often blank.
In context
| Measure | Drug Eluting Permanent Left Ventricular Lv Pacemaker Electrode | Product code OJX | All MAUDE reports |
|---|---|---|---|
| Reports | 1,234 | 52,462 | 26,136,888 |
| Share of that pool | — | 2.4% | 0% |
| Classified as death, per 1,000 reports | 3 | 35 | 9 |
| Classified as injury | 34.1% | 56.2% | 36.2% |
| Classified as malfunction | 65.5% | 40.2% | 62.3% |
| Filed by the manufacturer | 0% | 96.9% | 94.9% |
Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Other brands with product code OJX
| Brand | Reports | Latest 12 months | Classified as death |
|---|---|---|---|
| Quartet | 14,149 | 848 | 5.2% |
| Attain Ability | 5,253 | 0 | 4.4% |
| Attain Performa MRI SureScan | 4,795 | 647 | 1.4% |
| Attain Stability Quad MRI SureScan | 4,176 | 837 | 1.3% |
| Attain Performa | 3,995 | 0 | 1.8% |
| Attain Performa S MRI SureScan | 3,158 | 440 | 1.6% |
| Quickflex Micro Lv Lead | 3,702 | 116 | 5.9% |
| Attain Performa Straight MRI SureScan | 2,065 | 271 | 1.7% |
| Easytrak 2 | 4,260 | 18 | 0.8% |
| Attain Ability Plus | 1,887 | 0 | 2.9% |
| Sentus ProMRI OTW QP L-85/49 | 1,684 | 249 | 0.5% |
| Acuity | 3,848 | 6 | 1% |
| Attain Ability MRI SureScan | 1,344 | 162 | 0.3% |
| Quartet Lead Double Bend, 86 cm | 1,207 | 91 | 2.6% |
| Quicksite Lv | 1,718 | 13 | 7.2% |
Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."
Questions about Drug Eluting Permanent Left Ventricular Lv Pacemaker Electrode reports
How many FDA reports name Drug Eluting Permanent Left Ventricular Lv Pacemaker Electrode?
1,234 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 80 in the latest 12 months.
What kinds of events are reported?
malfunction (65.5%), injury (34.1%) and death (0.3%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.
What device problems are coded?
insufficient device problem information (14.5%), failure to capture (6.6%), therapeutic or diagnostic output failure (6.2%), device dislodged or dislocated (6%) and high capture threshold (4.2%). These are FDA's device problem codes as entered on the report.
Who files these reports?
voluntary reports (100%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.
Do these reports show that Drug Eluting Permanent Left Ventricular Lv Pacemaker Electrode was at fault?
No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."
How do I report a problem with a medical device?
Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.
Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.
Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.